Clinical Pipeline
Evidence Based Therapeutic DevelopmentHealgenetiX clinical research programs are conducted to scientifically evaluate the safety and efficacy of new drugs and biotechnological treatment solutions. Our clinical studies are designed in accordance with international research standards and are carried out under the supervision of independent ethics committees.
The primary aim of our research is to provide patients with safer, more effective, and innovative treatment options.
Clinical Research Processes
The HealgenetiX clinical research program prioritizes scientific accuracy and patient safety at every stage of the drug development process.
Phase I – Safety Studies
In this phase, the safety of the newly developed treatment is evaluated in humans. How the drug behaves in the body and its potential side effects are analyzed.